ReAlta is a proud partner to Hope For HIE, an organization that brings together families, clinicians, researchers, partners, supporters and others to spread awareness about neonatal and childhood acquired Hypoxic Ischemic Encephalopathy (HIE). Hope for HIE is the premier global patient advocacy organization for neonatal and pediatric HIE dedicated to improving the quality of life for children and families affected by HIE. ReAlta has an upcoming Phase 2 “STAR” clinical study that will assess RLS-0071, our lead candidate therapy, in newborns with HIE. More information on the trial can be found here: NCT05778188
This year, the community theme is CONNECTED BY HOPE. Hope inspires advocacy, change, creativity, support, community, and connection. As part of this theme, we are sharing Hope For HIE’s #ConnectedbyHope toolkit! The kit provides many resources to spread awareness about this rare disease.
Learn more and download the free #HIEAwarenessMonth toolkit here: 2023-HIE-Awareness-Month-Toolkit
Key Dates For HIE Awareness Month:
For more information about HIE Awareness Month and Hope For HIE, please visit www.hopeforhie.org
Dr. Neel Krishna and Dr. Katherine LaVallee, DVM did an outstanding job leading tours of our lab and offices last...Read More
We want to thank Rep. Elaine Luria and Norfolk Mayor Dr. Kenneth Alexander for helping us celebrate the official opening...Read More
ReAlta Life Sciences is officially part of Team Hope! We are extending our gratitude to the Hope for HIE team...Read More